Brain Care Study: Memory Screening and Support for Older Adults With Type 2 Diabetes
Tests a multidomain program to slow memory decline in older adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)
Key facts
- Where
- Copenhagen and Herlev, DenmarkSee the 3 sites
Where in Denmark
- Department of Endocrinology, Bispebjerg-Frederiksberg HospitalCopenhagen, DenmarkTaking people
- Department of Endocrinology, RigshospitaletCopenhagen, DenmarkTaking people
- Steno Diabetes Center CopenhagenHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Steno Diabetes Center Copenhagen
- Trial code
- NCT07250789
- Record updated
- 26 November 2025
- Original description
The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.Read full original descriptionShow less
Cognitive Screening of Individuals Diagnosed With Type 2 Diabetes and the Impact of a Multidomain Intervention Targeting Cognitive Decline (The Brain Care Study)
The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.
Inclusion: Age ≥ 65 years; Diagnosis of Type 2 Diabetes (T2D); Patient at the outpatient clinic at either Bispebjerg Hospital, Rigshospitalet, or Steno Diabetes Center Copenhagen; Speaks and understands Danish (required for the cognitive tests); Informed written consent; Meets all the above inclusion criteria, and at least one of the following:; A diabetes-specific dementia score ≥ 7 (equivalent to a 40% increased risk of developing dementia within the next 10 years), and a SCIP or MoCA score ≥ 0.5 SD below the age- and education-adjusted norm; A SCIP or MoCA score ≥ 1 SD below the age- and education-adjusted norm; At least 2 out of 5 SCIP subtests with a score ≥ 1 SD below the age- and education-adjusted norm.
Exclusion: Diagnosis of dementia or prior referral to a dementia clinic; Diagnosis of psychiatric, neurological, or other disorders that, in the investigator's opinion, hinder participation in cognitive screening, preclude compliance with the study protocol, or affect the evaluation of results; Participants whose cognitive MoCA screening indicates dementia will be excluded and advised to contact their physician; Meets all the above exclusion criteria; Participants unwilling to engage in parts of the multidomain intervention will be excluded.